Puneet Souda
Stock Analyst at Leerink Partners
(1.60)
# 3,187
Out of 4,843 analysts
213
Total ratings
47.98%
Success rate
-1.39%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $5.20 | +53.85% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $7.27 | +23.80% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $62.17 | +20.64% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $4.19 | +401.19% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $5.69 | -29.64% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $26.61 | +50.32% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $157.73 | -4.90% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $349.24 | +7.38% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $6.04 | +65.70% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $402.82 | +56.40% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $15.97 | +119.16% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $111.92 | +29.56% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $189.90 | +57.98% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $82.24 | +203.99% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $48.40 | +127.27% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $56.28 | +33.26% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $118.07 | +69.39% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.02 | +791.09% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.27 | +372.44% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $29.30 | +2.39% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $36.70 | +137.06% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $40.62 | +244.66% | 5 | Feb 24, 2022 |
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $5.20
Upside: +53.85%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $7.27
Upside: +23.80%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $62.17
Upside: +20.64%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $4.19
Upside: +401.19%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $5.69
Upside: -29.64%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $26.61
Upside: +50.32%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $157.73
Upside: -4.90%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $349.24
Upside: +7.38%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $6.04
Upside: +65.70%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $402.82
Upside: +56.40%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $15.97
Upside: +119.16%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $111.92
Upside: +29.56%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $189.90
Upside: +57.98%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $82.24
Upside: +203.99%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $48.40
Upside: +127.27%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $56.28
Upside: +33.26%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $118.07
Upside: +69.39%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.02
Upside: +791.09%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.27
Upside: +372.44%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $29.30
Upside: +2.39%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $36.70
Upside: +137.06%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $40.62
Upside: +244.66%